Diflucan, Fluconazole Newswire

Diflucan, Fluconazole Newswire

Comprehensive Real-Time News Feed for Diflucan, Fluconazole (generic).

Results 1 - 20 of 82 in Diflucan, Fluconazole (generic)

  1. Billy DuckettRead the original story w/Photo

    Apr 29, 2016 | POZ

    I have been with the same partner for 15 years and then some. My boyfriend and I were not having sex as a couple but were still very much together.

    Comment?

  2. In the DenRead the original story w/Photo

    Wednesday Nov 30 | POZ

    No. 11 cover boy Henry Nicols decided to go public with his HIV positive status when he was 17. A person with hemophilia, Nicols learned he was HIV positive when he was 11. Since going public, he and his sister Jennifer have spread the educational word to students of all ages around the country and the world. Temporarily "retired" from speaking, Nicols now spends time with his family and leads Boy Scout Troop #1254 in Cooperstown, New York.

    Comment?

  3. No Prescription. Cheap Online Generic Diflucan. Best Approved Online DrugStoreRead the original story

    Tuesday Nov 22 | Hernando Today

    Safe Place To Buy Diflucan online. Diflucan is an antifungal antibiotic used to treat yeast infections, urinary tract infections, peritonitis, pneumonia, AIDS cryptoccal infections.

    Comment?

  4. Matinas BioPharma Initiates Enrollment And Commences Patient Dosing...Read the original story

    Sunday Nov 20 | BioSpace

    Matinas BioPharma Holdings, Inc. , a clinical-stage biopharmaceutical company focused on identifying and developing safe and effective broad spectrum therapeutics for the treatment of serious and life-threatening infections, announced today that it has initiated enrollment and the first group of patients have been dosed in its Phase 2 clinical study of lead anti-infective product candidate MAT2203 in patients with vulvovaginal candidiasis .

    Comment?

  5. Cidara Provides Corporate Update and Reports Third Quarter 2016 Financial ResultsRead the original story

    Thursday Nov 10 | P&T Community

    Cidara Therapeutics, Inc. , a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial results for the three months ended September 30, 2016 and provided an update on its corporate activities and product pipeline. "Cidara made major progress in the third quarter and achieved significant clinical and corporate milestones.

    Comment?

  6. New superbug, Candida auris, detected in the USRead the original story

    Saturday Nov 5 | Crofs Blogs

    Just five months after federal health officials asked hospitals and physicians to be on the lookoutfor an often-fatal, antibiotic-resistant fungus called Candida auris , 13 cases have been reported, the Centers for Disease Control and Prevention announced Friday. It is the first time that the fungus, which is easily misidentified in lab tests as a more common candida yeast infection, has been found in the US, and four of the first seven patients with it have died.

    Comment?

  7. CDC: superbug fungus may have passed through US health facilitiesRead the original story

    Friday Nov 4 | SlashGear.com

    According to a new report from the Centers for Disease Control, a 'superbug' fungus called Candida auris may have passed through some health care facilities in the United States, marking a 'need for attention' amongst such facilities to help stop its spread. This fungus, unfortunately, is resistant to many anti-fungal medications, and was first isolated in Japan.

    Comment?

  8. New Killer Fungus Found in U.S. PatientsRead the original story w/Photo

    Friday Nov 4 | MSNBC

    A newly identified fungus that can kill very sick patients has been found in U.S. hospitals and has probably been here for a few years, federal health officials reported Friday. The yeast is called Candida auris and was first identified in 2009 in a Japanese patient with an ear infection.

    Comment?

  9. Fungal superbug linked to death of 4 AmericansRead the original story w/Photo

    Friday Nov 4 | Fox News

    Just five months after federal health officials asked hospitals and physicians to be on the lookout for an often-fatal, antibiotic-resistant fungus called Candida auris , 13 cases have been reported, the Centers for Disease Control and Prevention announced Friday. It is the first time that the fungus, which is easily misidentified in lab tests as a more common candida yeast infection, has been found in the US, and four of the first seven patients with it have died.

    Comment?

  10. Fluconazole Market Research, Size, Share Analysis by Manufacturers,...Read the original story

    Nov 3, 2016 | Emailwire.com

    Fluconazole Market is expected to witness growth of international market with respect to advancements and innovations including development history, competitive analysis and regional development forecast. The report starts with a basic Fluconazole market overview.

    Comment?

  11. Pfizer fined for hazardous chemical violations at Puerto Rico plantRead the original story w/Photo

    Oct 26, 2016 | In-PharmaTechnologist.com

    The US Environmental Protection Agency has fined Pfizer $190,000 for failing to disclose that it had ammonia and methylamine at its facility in Barceloneta, Puerto Rico. EPA inspectors who visited the drug manufacturing plant in 2014 found that ammonia and methylamine were present in amounts above the regulatory limit and without proper disclosure, which is a requirement of the Clean Air Act .

    Comment?

  12. Azole Affinity of Sterol 14I -Demethylase (CYP51) Enzymes from Candida albicans and Homo sapiensRead the original story

    Oct 19, 2016 | CiteULike

    Antimicrobial Agents and Chemotherapy , Vol. 57, No. 3. , pp. 1352-1360, doi:10.1128/aac.02067-12 Candida albicans CYP51 , full-length Homo sapiens CYP51 , and truncated I'60HsCYP51 were expressed in Escherichia coli and purified to homogeneity.

    Comment?

  13. Three-Dimensional Models of Wild-Type and Mutated Forms of Cytochrome ...Read the original story

    Oct 19, 2016 | CiteULike

    Antimicrobial Agents and Chemotherapy , Vol. 48, No. 2. , pp. 568-574, doi:10.1128/aac.48.2.568-574.2004 The cytochrome P450 sterol 14I -demethylase enzyme is the target of azole antifungals.

    Comment?

  14. Viamet Pharma's VT-1161 nabs QIDP and Fast Track status for treatment of recurrent yeast infectionRead the original story w/Photo

    Oct 12, 2016 | Seeking Alpha

    The FDA designates Viamet Pharmaceuticals' lead product candidate VT-1161 a Qualified Infectious Disease Product for Fast Track review for the treatment of recurrent vulvovaginal candidiasis or recurrent vaginal yeast infection, a difficult-to-treat condition affecting 5 - 8% of American women of child-bearing age. QIDP status provides for an additional five years of market exclusivity, if approved.

    Comment?

  15. Why SCYNEXIS, Inc. Is Making A RunRead the original story

    Oct 6, 2016 | BioSpace

    Scynexis shares made a handy gain early on Thursday after the company announced the results from a couple of its mid-stage trials. Specifically, the company evaluated two Phase 2 studies of SCY-078 and the results were very favorable.

    Comment?

  16. SCYNEXIS, Inc. Announces Complete Results From Two Phase II Studies...Read the original story

    Oct 5, 2016 | BioSpace

    SCYNEXIS, Inc. Announces Complete Results From Two Phase II Studies Of Oral SCY-078 In Patients With Candida Spp. Infections And Closing Of A $15 Million Term Loan JERSEY CITY, N.J., Oct. 05, 2016 -- Drug development company SCYNEXIS, Inc. today announced the complete results of its two recently completed Phase 2 studies as well as the closing of a $15 million term loan with Solar Capital Ltd. .

    Comment?

  17. SCYNEXIS' lead product candidate SCY-078 shows positive effect in two ...Read the original story w/Photo

    Oct 5, 2016 | Seeking Alpha

    Micro cap SCYNEXIS is up 20% after hours on robust volume in response to its announcement of encouraging results from two Phase 2 studies assessing lead product candidate SCY-078 for the treatment of vulvovaginal candidiasis or vaginal yeast infection. The first study, VVC patients receiving oral SCY-078 showed better cure rates and fewer recurrences of VVC at Month 4 of follow-up compared to standard-of-care treatment with oral fluconazole.

    Comment?

  18. SCYNEXIS Announces Complete Results from Two Phase 2 Studies of Oral...Read the original story w/Photo

    Oct 5, 2016 | GlobeNewswire

    SCYNEXIS Announces Complete Results from Two Phase 2 Studies of Oral SCY-078 in Patients with Candida spp. Infections and Closing of a $15 Million Term Loan JERSEY CITY, N.J., Oct. 05, 2016 -- Drug development company SCYNEXIS, Inc. today announced the complete results of its two recently completed Phase 2 studies as well as the closing of a $15 million term loan with Solar Capital Ltd. .

    Comment?

  19. Use of human clearance rates to predict the biotransformation of...Read the original story

    Sep 21, 2016 | U.S. Environmental Protection Agency

    Fay, K., C. LaLone, E. Durhan, M. Lee, L. Makynen, Dan Villeneuve, G. Ankley, J. Nichols, AND J. Berninger. Use of human clearance rates to predict the biotransformation of pharmaceuticals by fish: A test of the read-across approach.

    Comment?

  20. Current statins show calcium channel blocking activity through voltage gated channelsRead the original story w/Photo

    Sep 20, 2016 | BioMed Central

    Statins are used for treatment of hypercholestremia. Common adverse reports associated with use of statins are generalized bodyache, rhabdomyolysis, muscles weakness and gastrointestinal disorders.

    Comment?